Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 176 clinical trials
Rapid Recognition of Corticosteroid Resistant or Sensitive Sepsis

, 3, 4, 7, 10, 14, 28, and 90); Daily secondary infections (up to 90 days) Daily blood and urinary levels of glucose, sodium and potassium (up to 28 day) Daily

lactate level
norepinephrine
vasoconstrictors
pao2
shock
  • 0 views
  • 12 Apr, 2021
  • 1 location
SOX Versus XELOX as Adjuvant Chemotherapy for Stage III Colorectal Cancer Patients

-foot syndrome due to capecitabine as commonly prescribed. Meanwhile as another agent of fluorouracil, tegafurgimeracil and oteracil potassium (short for TGOP) has been shown with similar effect and

  • 0 views
  • 23 Jan, 2021
  • 1 location
A Clinical Study of HLX10 Combined With Chemotherapy Versus Placebo Combined With Chemotherapy for Neoadjuvant/Adjuvant Treatment of Gastric Cancer

neoadjuvant treatment phase, and chemotherapy alone will be administered during the adjuvant treatment phase. Chemotherapy regimen SOX (oxaliplatin + tegafor gimeracil oteracil potassium (S-1

gimeracil
adjuvant therapy
oxaliplatin
metastasis
cancer chemotherapy
  • 0 views
  • 24 Jan, 2021
  • 2 locations
Quality of Life of Frail Aged Patients in Incremental Hemodialysis

countries, imposed in the 70s. For incremental HD, the weekly dose of dialysis is based on variety of clinical factors such as residual kidney function, volume status, cardiovascular symptoms, potassium

dialysis
urine output
nephropathy
potassium
renal failure
  • 1 views
  • 29 Jan, 2021
  • 2 locations
Pembrolizumab/Placebo Plus Trastuzumab Plus Chemotherapy in Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-811/KEYNOTE-811)

The study will compare the efficacy and safety of pembrolizumab plus trastuzumab in combination with standard of care (SOC) chemotherapy versus trastuzumab in combination with SOC chemotherapy in participants with HER2-positive gastric cancer. The primary hypotheses of the study are that pembrolizumab plus trastuzumab in combination with chemotherapy is superior …

trastuzumab
solid tumour
cancer
human epidermal growth factor
capecitabine
  • 303 views
  • 04 Aug, 2021
  • 207 locations
Safety Tolerability and Efficacy of Rapid Optimization Helped by NT-proBNP testinG of Heart Failure Therapies

STRONG-HF is a multicenter, randomized, parallel group study designed to evaluate the efficacy and safety of up-titration of standard oral heart failure medications during hospitalization for acute heart failure. Patients admitted for acute heart failure will be randomized within 2 days before discharge to either usual care or intensification of …

edema
congestion
angiotensin
acute heart failure
nt-probnp
  • 119 views
  • 18 Feb, 2021
  • 158 locations
Spironolactone In The Treatment of Heart Failure

The purpose of this study is to determine whether the treatment of patients with HFmrEF and HFpEF at high risk of cardiovascular events with the mineralocorticoid receptor antagonist (MRA) spironolactone reduces a composite of recurrent heart failure hospitalizations and cardiovascular mortality.

  • 0 views
  • 03 Feb, 2021
  • 63 locations
Intensive Management of Blood Pressure and Cholesterol in Elderly Chinese With Hypertension and Atrial Fibrillation

Study name: Intensive management of blood pressure and cholesterol in elderly Chinese with hypertension and atrial fibrillation (IMPRESSION) Medicine: amlodipine/atorvastatin (5/10mg tablet); amlodipine/atorvastatin (5/20mg tablet); allisartan (240mg/tablet). Rationale: controlling blood pressure and cholesterol are both effective means to reduce cardiovascular risks, however, it is still unknown whether high cardiovascular risk …

cholesterol level
atrial fibrillation
atorvastatin
systolic blood pressure
hypertension
  • 0 views
  • 25 Jan, 2021
  • 1 location
GLP-1 and Hyperoxia for Organ Protection in Heart Surgery

Patients undergoing open heart surgery are at risk of suffering damage to the heart, brain and kidneys. This study is designed as a 2-by-2 randomized clinical trial with the purpose of investigating the organ protective effects of the glucagon-like-peptide-1 (GLP-1) agonist Exenatide versus placebo and restrictive versus liberal oxygenation during …

glucagon
heart surgery
aortic valve replacement
heart disease
ischemic heart disease
  • 36 views
  • 25 Apr, 2021
  • 1 location
Dietary Counseling or Potassium Supplement to Increase Potassium Intake in Patients With High Blood Pressure

dietary changes. Some effective dietary changes include decreasing sodium and increasing potassium in the diet. A lot of focus has been on sodium intake yet; potassium intake in the diet remains low

systolic blood pressure
blood pressure diastolic
cardiovascular disease
potassium
stroke
  • 12 views
  • 13 Mar, 2021
  • 1 location